# Dyne Therapeutics, Inc.: Form DEF 14A, filed Apr 22, 2022

- Company: [Dyne Therapeutics, Inc.](/companies/dyn.md) (CIK 1818794)
- Form: DEF 14A
- Filed: 2022-04-22
- Accepted by EDGAR: Apr 22, 2022, 16:15 ET
- Period: 2022-06-03
- Accession: 0000950170-22-006010
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1818794/000095017022006010/2021_proxy.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818794/000095017022006010/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818794/000095017022006010/2021_proxy.htm

Filed Apr 22, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-006010. Last ingested by Listed: Nov 5, 2026, 12:06 ET. No prices; not investment advice.